Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-13

Clinical Trial Update: A Study to Test the Safety of Combined Dosing With Aminophylline and Ambrisentan in Exercising Healthy Human Volunteers at Simulated High Altitude [Phase 1]

View source ↗

Summary

Phase 1 safety study evaluating the safety of combining aminophylline and ambrisentan in exercising healthy volunteers at simulated high altitude. The trial add…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambrisentan (Ambrisentan)
  • Aminophylline (aminophylline)

Snippet

Sponsor: Robert J Noveck, M.D. | Conditions: Acute Mountain Sickness and Fatigue | Phase 1 | Status: COMPLETED